You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

CLINICAL TRIALS PROFILE FOR WELCHOL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Welchol

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00147719 ↗	WelChol® With Metformin in Treating Patients With Type 2 Diabetes	Completed	Daiichi Sankyo Inc.	Phase 3	2004-06-01	The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs.
NCT00147719 ↗	WelChol® With Metformin in Treating Patients With Type 2 Diabetes	Completed	Daiichi Sankyo, Inc.	Phase 3	2004-06-01	The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs.
NCT00147745 ↗	Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes	Completed	Daiichi Sankyo Inc.	Phase 2	2005-06-01	This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes
NCT00147745 ↗	Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes	Completed	Daiichi Sankyo, Inc.	Phase 2	2005-06-01	This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes
NCT00147758 ↗	WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes	Completed	Daiichi Sankyo Inc.	Phase 3	2004-06-01	The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs.
NCT00147758 ↗	WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes	Completed	Daiichi Sankyo, Inc.	Phase 3	2004-06-01	The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs.
NCT00151749 ↗	WelChol® and Insulin in Treating Patients With Type 2 Diabetes	Completed	Daiichi Sankyo Inc.	Phase 3	2004-06-01	The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Welchol

Condition Name

Chart
Table

Condition Name for Welchol
Intervention	Trials
Type 2 Diabetes	7
Type 2 Diabetes Mellitus	5
Hypercholesterolemia	5
Dyslipidemia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Welchol
Intervention	Trials
Diabetes Mellitus, Type 2	13
Diabetes Mellitus	10
Hypercholesterolemia	5
Diarrhea	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Welchol

Trials by Country

Map
Table

Trials by Country for Welchol
Location	Trials
United States	243
Mexico	4
Peru	4
Canada	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Welchol
Location	Trials
California	16
Florida	14
Ohio	12
Minnesota	12
Texas	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Welchol

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Welchol
Clinical Trial Phase	Trials
Phase 4	13
Phase 3	7
Phase 2/Phase 3	1
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Welchol
Clinical Trial Phase	Trials
Completed	25
Recruiting	1
Terminated	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Welchol

Sponsor Name

Chart
Table

Sponsor Name for Welchol
Sponsor	Trials
Daiichi Sankyo Inc.	20
Daiichi Sankyo, Inc.	20
Mayo Clinic	5
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Welchol
Sponsor	Trials
Industry	48
Other	14
NIH	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.